Parisi, Melissa A.

Impairment of mitochondrial transcription termination by a point mutation associated with the MELAS subgroup of mitochondrial encephalomyopathies

Hess, J. F., Parisi, M. A., Bennett, J. L., & Clayton, D. A. (1991) · Nature

Mitochondrial Function and PathologyRNA and protein synthesis mechanisms

Cited by 234

Nutritional interventions in primary mitochondrial disorders: Developing an evidence base

Camp, K. M., Krotoski, D., Parisi, M. A., Gwinn, K. A., Cohen, B. H., Cox, C. S., Enns, G. M., Falk, M. J., Goldstein, A. C., Gopal-Srivastava, R., et al. (2016) · Molecular Genetics and Metabolism

Metabolism and Genetic DisordersMitochondrial Function and Pathology

Cited by 59

Timeline to symptomatic Alzheimer's disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort study

Schworer, E. K., Zammit, M. D., Wang, J., Handen, B. L., Betthauser, T., Laymon, C. M., Tudorascu, D. L., Cohen, A. D., Zaman, S. H., Ances, B. M., et al. (2024) · The Lancet Neurology

Dementia and Cognitive Impairment ResearchDown syndrome and intellectual disability research

Cited by 29